Proteomic Profiles in Human Temporal Lobe Epilepsy
Proteomic Profiles in Human Temporal Lobe Epilepsy
批准号:
7142814
负责人:
NIHAL C DE LANEROLLE
金额:
$22.28万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-07-01 至 2008-04-30
中文摘要
描述(申请人提供):美国约有250万人患有癫痫,全球约有4000万人患有癫痫。其中40%的人患有颞叶癫痫(TLE)。在约45%的TLE患者中,现有药物无法很好地控制癫痫发作。手术帮助了这些患者中的一部分,但仍然是一种昂贵的手术,有发病的风险。TLE的分子机制尚未完全阐明,但如果更好地了解,可能为治疗和/或治愈这种疾病提供新的途径。高通量筛选基因(基因组学)和蛋白质(蛋白质组)表达的方法的最新进展有望在解开这些分子机制方面取得更快的进展。我们已经开始从最近接受R21支持的TLE患者中鉴定与癫痫脑病灶的病理生理相关的各种基因和途径。然而,基因表达分析本身并不能提供关于已识别基因编码的实际蛋白质的可靠信息。由于编辑和剪接的不同,一个基因可以编码许多不同的蛋白质物种,它们的产物可能会出现翻译后修饰。在这项建议中,我们建议分析海马区癫痫灶中的蛋白质组,以补充正在进行的基因组研究。在这些研究中,我们将使用2-DGE分析来确定内侧颞叶癫痫合并海马硬化症(MTLE)的蛋白质谱特征。在异常性颞叶癫痫(PTLE)患者中,仅有1/2的患者在手术后经历癫痫发作缓解状态,蛋白质组学图谱将与手术结果进行比较,以阐明反应性差的患者的蛋白质组,作为发展这一群体的术前分子诊断的手段。这些研究对于确定TLE特有的分子是必不可少的,这将是未来探索它们在癫痫发病机制中作用的研究的候选(S)。
英文摘要
DESCRIPTION (provided by applicant): Epilepsy affects about 2.5 million people in the USA and 40 million worldwide. Of this population 40% are patients with temporal lobe Epilepsy (TLE). In approximately 45% of those with TLE, seizures cannot be well controlled by available medications. Surgery helps a proportion of these patients, but remains a costly procedure with a risk of morbidity. The molecular mechanisms of TLE are not yet fully elucidated, but if better known could provide new avenues for the treatment and/or cure of this disease. Recent developments in methods for high throughput screening of gene (genomics) and protein (proteomics) expression hold promise of more rapid progress in unravelling these molecular mechanisms. We have begun to identify various genes and pathways associated with the pathophysiology of epileptic brain foci from TLE patients supported by a recently received R21. However, gene expression analyses do not by themselves provide reliable information on the actual proteins encoded by identified genes. A single gene can encode many different protein species due to differences in editing and splicing, and their products may show post- translational modification. In this proposal we propose to analyze the proteome in hippocampal seizure foci, to complement genomic studies in progress. In these studies we will use 2-DIGE analyses to identify the protein profile that characterizes mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE). In patients with paradoxical temporal lobe epilepsy (PTLE), where only one in two patients experience seizure free status after surgery, proteomic profiles will be compared with surgical outcome, to elucidate the proteome of the poor responders, as a means to developing a presurgical molecular diagnosis of this group. These studies are essential to identify molecules unique to TLE, which will be the candidates for study in future research that explores their role(s) in seizure mechanisms.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Efficacy of Erythropoietin (EPO) and EPO Analogues in the Treatment of Epilepsy
-
批准号:7760151
-
项目类别:
-
资助金额:$17.92万
-
财政年份:2009
-
负责人:NIHAL C DE LANEROLLE
-
依托单位:
Proteomic Profiles in Human Temporal Lobe Epilepsy
-
批准号:7244023
-
项目类别:
-
资助金额:$18.02万
-
财政年份:2006
-
负责人:NIHAL C DE LANEROLLE
-
依托单位:
Genetic Signatures in Human Temporal Lobe Epilespy
-
批准号:6767219
-
项目类别:
-
资助金额:$18.9万
-
财政年份:2004
-
负责人:NIHAL C DE LANEROLLE
-
依托单位:
Genetic Signatures in Human Temporal Lobe Epilespy
-
批准号:6877123
-
项目类别:
-
资助金额:$22.69万
-
财政年份:2004
-
负责人:NIHAL C DE LANEROLLE
-
依托单位:
Neuroanotomical changes influencing glutamate in seizure foci
-
批准号:6616368
-
项目类别:
-
资助金额:$22.55万
-
财政年份:2002
-
负责人:NIHAL C DE LANEROLLE
-
依托单位:
Neuroanotomical changes influencing glutamate in seizure foci
-
批准号:6495439
-
项目类别:
-
资助金额:$22.55万
-
财政年份:2001
-
负责人:NIHAL C DE LANEROLLE
-
依托单位:
Neuroanotomical changes influencing glutamate in seizure foci
-
批准号:6335100
-
项目类别:
-
资助金额:$22.6万
-
财政年份:2000
-
负责人:NIHAL C DE LANEROLLE
-
依托单位:
Neuroanotomical changes influencing glutamate in seizure foci
-
批准号:6233748
-
项目类别:
-
资助金额:$22.6万
-
财政年份:1999
-
负责人:NIHAL C DE LANEROLLE
-
依托单位:
CHARACTERIZATION & DEVELOPMENT OF SEIZURE FOCUS
-
批准号:6336894
-
项目类别:
-
资助金额:$1.29万
-
财政年份:1998
-
负责人:NIHAL C DE LANEROLLE
-
依托单位:
MOLECULAR NEUROANATOMIC ANALYSIS OF EPILEPTOFORM HUMAN TEMPORAL LOBE TISSUE
-
批准号:6336893
-
项目类别:
-
资助金额:$1.29万
-
财政年份:1998
-
负责人:NIHAL C DE LANEROLLE
-
依托单位:
CHARACTERIZATION & DEVELOPMENT OF SEIZURE FOCUS
-
批准号:6251557
-
项目类别:
-
资助金额:$1.29万
-
财政年份:1997
-
负责人:NIHAL C DE LANEROLLE
-
依托单位:
MOLECULAR NEUROANATOMIC ANALYSIS OF EPILEPTOFORM HUMAN TEMPORAL LOBE TISSUE
-
批准号:6251556
-
项目类别:
-
资助金额:$1.29万
-
财政年份:1997
-
负责人:NIHAL C DE LANEROLLE
-
依托单位:
NEUROANATOMICAL DEFINITION OF THE EPILEPTOGENIC REGION
-
批准号:6112420
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1997
-
负责人:NIHAL C DE LANEROLLE
-
依托单位:
CHARACTERIZATION AND DEVELOPMENT OF A SEIZURE FOCUS
-
批准号:2266277
-
项目类别:
-
资助金额:$23.26万
-
财政年份:1989
-
负责人:NIHAL C DE LANEROLLE
-
依托单位:
CHARACTERIZATION & DEVELOPMENT OF A SEIZURE FOCUS
-
批准号:3413261
-
项目类别:
-
资助金额:$22.37万
-
财政年份:1989
-
负责人:NIHAL C DE LANEROLLE
-
依托单位:
CHARACTERIZATION AND DEVELOPMENT OF A SEIZURE FOCUS
-
批准号:2266278
-
项目类别:
-
资助金额:$19.96万
-
财政年份:1989
-
负责人:NIHAL C DE LANEROLLE
-
依托单位:
CHARACTERIZATION AND DEVELOPMENT OF A SEIZURE FOCUS
-
批准号:3413258
-
项目类别:
-
资助金额:$19.6万
-
财政年份:1989
-
负责人:NIHAL C DE LANEROLLE
-
依托单位:
CHARACTERIZATION AND DEVELOPMENT OF A SEIZURE FOCUS
-
批准号:3413259
-
项目类别:
-
资助金额:$17.53万
-
财政年份:1989
-
负责人:NIHAL C DE LANEROLLE
-
依托单位:
CHARACTERIZATION AND DEVELOPMENT OF A SEIZURE FOCUS
-
批准号:3413260
-
项目类别:
-
资助金额:$17.49万
-
财政年份:1989
-
负责人:NIHAL C DE LANEROLLE
-
依托单位:
CHARACTERIZATION AND DEVELOPMENT OF A SEIZURE FOCUS
-
批准号:3413257
-
项目类别:
-
资助金额:$17.28万
-
财政年份:1989
-
负责人:NIHAL C DE LANEROLLE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
精神分裂症脑网络异常的影像遗传学研究
-
批准号:81000582
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:刘冰
-
依托单位:
孤独症全基因组关联第二阶段研究
-
批准号:81071110
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:王力芳
-
依托单位:
孤独症与突触发育相关候选基因的关联研究
-
批准号:30870897
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2008
-
负责人:张岱
-
依托单位:
用dsDNA微阵列筛选NF-κB DNA靶点及靶基因
-
批准号:60871014
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2008
-
负责人:王进科
-
依托单位:
大鱼际掌纹特应征与5个哮喘易感基因单核苷酸多态性的关联分析
-
批准号:30873315
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2008
-
负责人:周兆山
-
依托单位: